Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Keval K. Patel"'
Autor:
Andrew Kichura, Keval K. Patel, Paul J. Hauptman, Eldin Duderija, Robert M. Hoerner, Vindeep Bhandari, Andrija Vidic, John T. Chibnall, Laurie E. Byrne
Publikováno v:
Archives of cardiovascular diseases. 113(12)
Summary Background Evaluation of patients with acute decompensated heart failure includes symptom review, biomarker measurement and comorbidity assessment. Early objective evaluation of functional status is generally not performed. Aim To investigate
Publikováno v:
Texas Heart Institute Journal. 43:152-155
Takotsubo cardiomyopathy, or transient left ventricular apical ballooning syndrome, is characterized by acute left ventricular dysfunction caused by transient wall-motion abnormalities of the left ventricular apex and mid ventricle in the absence of
Autor:
Anoop Agrawal, Wail Alkashkari, Subhash Banerjee, Ryan Berg, Emmanouil S. Brilakis, Qi Ling Cao, Mauro Carlino, Cheng-Han Chen, Michael Forsberg, Philippe Genereux, Tarek Helmy, James Hermiller, Ziyad M. Hijazi, Morton J. Kern, Ajay J. Kirtane, Andrew J. Klein, Michael J. Lim, Yves Louvard, Ammar Nasir, Keval K. Patel, Pranav M. Patel, Matthew J. Price, Rahil Rafeedheen, Stephane Rinfret, Jason H. Rogers, Arang Samim, Arnold J. Seto, Gagan D. Singh, Paul Sorajja, Jose D. Tafur, Barry F. Uretsky, Christopher J. White
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::971e087c2867093fc1cfd52abf3a5cc6
https://doi.org/10.1016/b978-0-323-47671-3.00024-7
https://doi.org/10.1016/b978-0-323-47671-3.00024-7
Publikováno v:
Journal of Cardiac Failure. 21:968-972
It is conceivable that lean patients (body mass index 18.5-24.9 kg/m(2)) with heart failure (HF) have low body weight due to low food consumption and that this may contribute to micronutrient deficiencies and to their poorer prognosis compared with o
Autor:
Keval K. Patel, Ali Mehdirad, Scott W Ferreira, Joshua M. Stolker, Michael J. Lim, Peter Mikolajczak
Publikováno v:
Journal of Hospital Medicine. 9:400-406
BACKGROUND Warfarin reduces stroke in patients with atrial fibrillation. However, its narrow therapeutic index and need for chronic monitoring are barriers to its optimal utilization in many patients. The recent introduction of 3 novel oral anticoagu
Publikováno v:
Anticoagulation Therapy
Atrial fibrillation (AF) is a very common clinically significant arrhythmia noted in clinical practice. Its incidence increases with age and along with advanced age, other risk factors such hypertension, vascular disease, heart failure, diabetes, pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d857effda4dabb76cdacb10e0f8b81b5
http://www.intechopen.com/articles/show/title/non-vitamin-k-antagonist-oral-anticoagulants-in-atrial-fibrillation-pharmacology-and-phase-iii-clini
http://www.intechopen.com/articles/show/title/non-vitamin-k-antagonist-oral-anticoagulants-in-atrial-fibrillation-pharmacology-and-phase-iii-clini
Publikováno v:
Journal of the American College of Cardiology. 69:2467
Autor:
Keval K, Patel, Ali A, Mehdirad, Michael J, Lim, Scott W, Ferreira, Peter C, Mikolajczak, Joshua M, Stolker
Publikováno v:
Journal of hospital medicine. 9(6)
Warfarin reduces stroke in patients with atrial fibrillation. However, its narrow therapeutic index and need for chronic monitoring are barriers to its optimal utilization in many patients. The recent introduction of 3 novel oral anticoagulants (NOAC
Autor:
Patel K; The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India. drkevalpatel@yahoo.com.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2024 Nov 23. Date of Electronic Publication: 2024 Nov 23.